Detailed answers about ACTIVATE CLINICAL RESEARCH HOLDINGS LTD, including incorporation, status, business activity, and accounts information.
When was ACTIVATE CLINICAL RESEARCH HOLDINGS LTD founded?
ACTIVATE CLINICAL RESEARCH HOLDINGS LTD was officially incorporated on 27 September 2024 and is registered under company number 15983977. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is ACTIVATE CLINICAL RESEARCH HOLDINGS LTD?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of ACTIVATE CLINICAL RESEARCH HOLDINGS LTD?
ACTIVATE CLINICAL RESEARCH HOLDINGS LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does ACTIVATE CLINICAL RESEARCH HOLDINGS LTD do?
ACTIVATE CLINICAL RESEARCH HOLDINGS LTD operates in the following sector: 64209 - Activities of other holding companies n.e.c.. This provides insight into the company's primary business activity and industry focus.
What is ACTIVATE CLINICAL RESEARCH HOLDINGS LTD's registered address?
The registered office address of ACTIVATE CLINICAL RESEARCH HOLDINGS LTD is 1110 ELLIOTT COURT COVENTRY BUSINESS PARK, HERALD AVENUE, COVENTRY, WEST MIDLANDS, UNITED KINGDOM, CV5 6UB. This is the official address filed with Companies House for legal and statutory correspondence.
Is ACTIVATE CLINICAL RESEARCH HOLDINGS LTD financially stable?
Financial accounts for ACTIVATE CLINICAL RESEARCH HOLDINGS LTD are not currently available. Without filed accounts, it is more difficult to assess the company's financial stability and trading performance.